Back to Search
Start Over
Lipella Pharmaceuticals Initiates Phase 2a Trial For LP-310 in Oral Lichen Planus, Enrolls First Patients
- Source :
- Plus Company Updates. July 29, 2024
- Publication Year :
- 2024
-
Abstract
- PITTSBURGH: Lipella Pharmaceuticals Inc., announces the enrollment of the first patients in its multi-center Phase 2a clinical trial evaluating LP-310 for the treatment of Oral Lichen Planus (OLP). This chronic [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.803456022